Quantum vaccinomics platforms to advance in vaccinology.
immunology
quantum
vaccine
vaccinology
vaccinomics
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
02
2023
accepted:
05
06
2023
medline:
5
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
The opinion flows from Introduction to the immunological quantum that requires a historical perspective, to Quantum vaccine algorithms supported by a bibliometric analysis, to Quantum vaccinomics describing from our perspective the different vaccinomics and quantum vaccinomics algorithms. Finally, in the Discussion and conclusions we propose novel platforms and algorithms developed to further advance on quantum vaccinomics. In the paper we refer to protective epitopes or immunological quantum for the design of candidate vaccine antigens, which may elicit a protective response through both cellular and antibody mediated mechanisms of the host immune system. Vaccines are key interventions for the prevention and control of infectious diseases affecting humans and animals worldwide. Biophysics led to quantum biology and quantum immunology reflecting quantum dynamics within living systems and their evolution. In analogy to quantum of light, immune protective epitopes were proposed as the immunological quantum. Multiple quantum vaccine algorithms were developed based on omics and other technologies. Quantum vaccinomics is the methodological approach with different platforms used for the identification and combination of immunological quantum for vaccine development. Current quantum vaccinomics platforms include
Identifiants
pubmed: 37398646
doi: 10.3389/fimmu.2023.1172734
pmc: PMC10307952
doi:
Substances chimiques
Vaccines
0
Antigens
0
Epitopes
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1172734Informations de copyright
Copyright © 2023 de la Fuente and Contreras.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Proc Math Phys Eng Sci. 2018 Dec;474(2220):20180674
pubmed: 30602940
Med Res Arch. 2021 Jul;9(7):
pubmed: 34853815
Methods Mol Biol. 2022;2411:287-305
pubmed: 34816412
Front Immunol. 2018 Jan 12;8:2009
pubmed: 29387066
PLoS Pathog. 2011 Dec;7(12):e1002344
pubmed: 22241978
iScience. 2023 Apr 18;26(5):106697
pubmed: 37168564
AAPS J. 2011 Sep;13(3):438-44
pubmed: 21671143
Vaccines (Basel). 2022 Nov 24;10(12):
pubmed: 36560405
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852802
Expert Rev Vaccines. 2021 Dec;20(12):1561-1569
pubmed: 34582295
Immunology. 2022 Oct;167(2):139-153
pubmed: 35752944
Vaccine. 2013 Dec 2;31(49):5889-96
pubmed: 24084474
Vaccine. 2013 Feb 6;31(8):1187-96
pubmed: 23291476
Front Immunol. 2020 Jun 25;11:1181
pubmed: 32670279
Public Health Genomics. 2013;16(1-2):62-8
pubmed: 23548719
Front Immunol. 2019 Jul 25;10:1722
pubmed: 31404139
Ann Med. 2022 Dec;54(1):2535-2548
pubmed: 36111779
Brief Bioinform. 2021 Nov 5;22(6):
pubmed: 33979434
Expert Rev Vaccines. 2016 Aug;15(8):953-5
pubmed: 27100121
Front Chem. 2015 Feb 10;3:9
pubmed: 25713797
Methods Mol Biol. 2014;1184:333-64
pubmed: 25048134
Vaccine. 2003 Mar 28;21(13-14):1492-501
pubmed: 12615446
Springerplus. 2013 Dec;2(1):7
pubmed: 23483108
Expert Rev Vaccines. 2018 Jul;17(7):569-576
pubmed: 29953298
Clin Pharmacol Ther. 2007 Dec;82(6):623-6
pubmed: 17998905
Vaccines (Basel). 2020 Aug 02;8(3):
pubmed: 32748849
Trends Parasitol. 2014 Aug;30(8):401-11
pubmed: 25028089
Vaccine. 2022 Jul 30;40(32):4564-4573
pubmed: 35728991
Curr Top Med Chem. 2018;18(32):2774-2799
pubmed: 30747069
Vaccine. 2010 Jul 26;28(33):5398-406
pubmed: 20594626
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34185681
Vaccines (Basel). 2022 Aug 16;10(8):
pubmed: 36016215
Innovation (Camb). 2021 Aug 28;2(3):100126
pubmed: 34124705
Front Cell Infect Microbiol. 2017 Aug 09;7:360
pubmed: 28848718
Curr Opin Immunol. 2011 Jun;23(3):436-43
pubmed: 21570272
Biologicals. 2001 Sep-Dec;29(3-4):209-13
pubmed: 11851317
Vaccine. 2013 Dec 5;31(50):5923-9
pubmed: 24396872
Eur J Immunol. 2023 Apr;53(4):e2250206
pubmed: 36658749
Front Public Health. 2018 Mar 05;6:62
pubmed: 29556492
Adv Protein Chem Struct Biol. 2022;130:1-38
pubmed: 35534105
Bioinformatics. 2014 Aug 15;30(16):2381-3
pubmed: 24790156
World J Radiol. 2022 Jun 28;14(6):114-136
pubmed: 35978978
PLoS One. 2014 Dec 29;9(12):e115745
pubmed: 25545691
Vaccines (Basel). 2020 Feb 08;8(1):
pubmed: 32046307
Int J Mol Sci. 2016 Sep 21;17(9):
pubmed: 27657055